ClariVest Asset Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $2.28M | Buy |
|
|||||
|
2023
Q3 | $1.44M | Sell |
|
|||||
|
2023
Q2 | $1.75M | Buy |
|
|||||
|
2023
Q1 | $1.14M | Sell |
|
|||||
|
2022
Q4 | $824K | Sell |
|
|||||
|
2022
Q3 | $465K | Hold |
|
|||||
|
2022
Q2 | $392K | Hold |
|
|||||
|
2022
Q1 | $413K | Sell |
|
|||||
|
2021
Q4 | $515K | Buy |
|
|||||
|
2021
Q3 | $415K | Sell |
|
|||||
|
2021
Q2 | $498K | Hold |
|
|||||
|
2021
Q1 | $518K | Buy |
|
|||||
|
2020
Q4 | $514K | Sell |
|
|||||
|
2020
Q3 | $766K | Sell |
|
|||||
|
2020
Q2 | $392K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $105K | Buy |
|